Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Peripheral vascular devices include the devices used to treat peripheral vascular disease (PVD). Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension. GlobalData uses proprietary data and analytics to provide a comprehensive report on the renal denervation catheters market in Switzerland. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the renal denervation catheters market in Switzerland was Boston Scientific followed by Medtronic and Otsuka Medical Devices.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

The Renal Denervation Catheter market consists of Radiofrequency Catheters, Ultrasound Catheters and Micro-Infusion Catheters. Radiofrequency Catheters are used to deliver high frequency alternating current (in the range of 300-500 kHz) to ablate nerves in the renal artery. Ultrasound catheters are used to deliver high frequency sound waves (i.e. , rapid mechanical oscillations) to destroy the renal nerves. Micro-infusion catheters are used to deliver chemical agents, such as ethanol, to denervate the renal arteries.

The renal denervation catheters market in Switzerland can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size renal denervation catheters in Switzerland, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.